Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Matsuyama, Shutoku

Class:Id	Person:9681508
_displayName	Matsuyama, Shutoku
_timestamp	2020-04-02 11:02:02
created	[InstanceEdit:9681510] Jassal, Bijay, 2020-04-02
firstname	Shutoku
initial	S
surname	Matsuyama
(author)	[LiteratureReference:9681519] Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry [LiteratureReference:9684962] Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay [LiteratureReference:9685466] Two palmitylated cysteine residues of the severe acute respiratory syndrome coronavirus spike (S) protein are critical for S incorporation into virus-like particles, but not for M-S co-localization [LiteratureReference:9687564] Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2
[Change default viewing format]

No pathways have been reviewed or authored by Matsuyama, Shutoku (9681508)